000179755 001__ 179755
000179755 005__ 20240229145553.0
000179755 0247_ $$2doi$$a10.1016/j.ejca.2022.03.028
000179755 0247_ $$2pmid$$apmid:35490564
000179755 0247_ $$2ISSN$$a0014-2964
000179755 0247_ $$2ISSN$$a0959-8049
000179755 0247_ $$2ISSN$$a1879-0852
000179755 0247_ $$2ISSN$$a(1990)
000179755 0247_ $$2ISSN$$a1879-2995
000179755 0247_ $$2ISSN$$a(1965)
000179755 0247_ $$2altmetric$$aaltmetric:127580306
000179755 037__ $$aDKFZ-2022-00882
000179755 041__ $$aEnglish
000179755 082__ $$a610
000179755 1001_ $$aFerrari, Andrea$$b0
000179755 245__ $$aThe treatment approach to pediatric non-rhabdomyosarcoma soft tissue sarcomas: a critical review from the INternational Soft Tissue SaRcoma ConsorTium.
000179755 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2022
000179755 3367_ $$2DRIVER$$aarticle
000179755 3367_ $$2DataCite$$aOutput Types/Journal article
000179755 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1651499650_31599$$xReview Article
000179755 3367_ $$2BibTeX$$aARTICLE
000179755 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000179755 3367_ $$00$$2EndNote$$aJournal Article
000179755 520__ $$aThe current article focuses on non-rhabdomyosarcoma soft tissue sarcoma (NRSTS), the heterogeneous group of mesenchymal tumours different from rhabdomyosarcoma that may affect children and adolescents, with clinical behaviour varying from relatively benign to highly malignant. This review represents the effort of the international scientific paediatric community within the context of the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT), a project founded by the leadership of three large cooperative groups - Children's Oncology Group, Cooperative Weichteilsarkom Studiengruppe and European paediatric Soft tissue sarcoma Study Group - with the main goal to pool expertise and resources on a broader international level in order to improve knowledge of soft tissue sarcomas of children, adolescents and young adults. This article describes the current standard treatment approach in NRSTS, with a focus on the controversies and challenges in the management of these tumours. Developing research projects and clinical protocols for NRSTS has always been challenging, supporting the need to develop international integrated prospective dedicated programs, including paediatric NRSTS experts together with the adult sarcoma community. INSTRuCT provides a unique mechanism to increase international collaboration by agreeing on a common language, developing consensus standards to guide diagnosis and treatment, comparing clinical trial results across cooperative groups, and through a shared data dictionary providing answers to questions that can only be addressed by a larger data set.
000179755 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000179755 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000179755 650_7 $$2Other$$aINSTRuCT
000179755 650_7 $$2Other$$aNRSTS
000179755 650_7 $$2Other$$aNon-rhabdomyosarcoma soft tissue sarcomas
000179755 650_7 $$2Other$$aReview
000179755 650_7 $$2Other$$aStandard
000179755 650_7 $$2Other$$aTreatment
000179755 7001_ $$aOrbach, Daniel$$b1
000179755 7001_ $$aSparber-Sauer, Monika$$b2
000179755 7001_ $$aWalterhouse, David O$$b3
000179755 7001_ $$0P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aPajtler, Kristian W$$b4$$udkfz
000179755 7001_ $$aMeyer, William H$$b5
000179755 7001_ $$aSpunt, Sheri L$$b6
000179755 7001_ $$aWeiss, Aaron R$$b7
000179755 773__ $$0PERI:(DE-600)1468190-0$$a10.1016/j.ejca.2022.03.028$$gVol. 169, p. 10 - 19$$p10 - 19$$tEuropean journal of cancer$$v169$$x0014-2964$$y2022
000179755 909CO $$ooai:inrepo02.dkfz.de:179755$$pVDB
000179755 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a7c1bbac024fa232d9c6b78443328d9d$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000179755 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000179755 9141_ $$y2022
000179755 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000179755 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000179755 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000179755 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-30$$wger
000179755 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J CANCER : 2021$$d2022-11-30
000179755 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-30
000179755 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-30
000179755 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-30
000179755 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-30
000179755 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-30
000179755 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-30
000179755 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-30
000179755 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-30
000179755 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-30
000179755 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bEUR J CANCER : 2021$$d2022-11-30
000179755 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000179755 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x1
000179755 980__ $$ajournal
000179755 980__ $$aVDB
000179755 980__ $$aI:(DE-He78)B062-20160331
000179755 980__ $$aI:(DE-He78)HD01-20160331
000179755 980__ $$aUNRESTRICTED